Paxalisib in DIPG, Phase I, has finally been set to ”completed“ at Clintrials with 4th September 2022 as the actual study completion date: https://clinicaltrials.gov/ct2/show/NCT03696355I am hoping results will be published soon.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
